Vibhavadi Medical Center Public Company (VIBHA) Fair Value & Analysis
Healthcare · TH · Market cap 18.2B THB
Fair value as of: Jul 17, 2026
From 26 valuation models · updated 24 days ago
Share price −1.5% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (0.9300 THB to 1.82 THB) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range 1.28 THB – 2.63 THB · fair‑value band 0.9300 THB – 1.82 THB · the 1.35 THB price screens below the 1.46 THB fair value. Dashed = 300-day average. As of Jul 17, 2026.
Analysis
Vibhavadi Medical Center Public Company (VIBHA) currently trades at 1.35 THB, while our model-based Fair Value estimate is 1.46 THB, implying the stock looks roughly 8.2% fairly valued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Vibhavadi Medical Center Public Company generated revenue of 5.7B THB at a net margin of 31.2%. Revenue declined 4.9% year over year. It earns a return on equity of 16.1%. Net debt stands at 6.6B THB. Fundamentals as of Jul 17, 2026
Our scenario range runs from 0.9300 THB (bear case) to 1.82 THB (bull case); at 1.35 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 8%, VIBHA screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (2.54 THB) versus Economic Profit (0.3100 THB). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 51 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Vibhavadi Medical Center Public Company Limited operates a hospital under the Vibhavadi Hospital name in Thailand. It operates through two segments, Hospital General Hospital and Hospital in Social Security; and Others Rental services and rental space. The company provides medical services; and rental services and space rental.
Full company description
Vibhavadi Medical Center Public Company Limited operates a hospital under the Vibhavadi Hospital name in Thailand. It operates through two segments, Hospital General Hospital and Hospital in Social Security; and Others Rental services and rental space. The company provides medical services; and rental services and space rental. It engages in the beauty business; and operation of anti-aging center and specialized disease clinics. The company was founded in 1986 and is based in Bangkok, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Vibhavadi Medical Center Public Company reported revenue of 5.6B THB in FY2025 versus 7.4B THB in FY2021, a compound −6.6%/yr. Reported net income was 1.7B THB in FY2025, compounding −1.6%/yr from FY2021.
Watch VIBHA: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Vibhavadi Medical Center Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Vibhavadi Medical Center Public Company (VIBHA) overvalued or undervalued?
What is the fair value of VIBHA?
What is the quality score of VIBHA?
What is the revenue of Vibhavadi Medical Center Public Company (VIBHA)?
What is the net profit margin of VIBHA?
Does Vibhavadi Medical Center Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Vibhavadi Medical Center Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.